Giorgio Racagni

Giorgio Racagni

Auto-generated profile, based on publicly available information

Giorgio Racagni

Department of Pharmacological and Biomolecular Sciences University of Milan Milan Italy

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2021 in Medicinal Research Reviews
Verified
Journal Article
Open access
PDF file
AMAndrea Magnavacca
Andrea Magnavacca
ESEnrico Sangiovanni
Enrico Sangiovanni
GRGiorgio Racagni
Giorgio Racagni
Mario Dell'agliMario Dell'agli
Mario Dell'agli
Propolis is a complex natural product that possesses antioxidant, anti‐inflammatory, immunomodulatory, antibacterial, and antiviral properties mainly attributed to the high content in flavonoids, phenolic acids, and their derivatives. The chemical composition of propolis is multifarious, as it depends on the botanical sources from which honeybees collect resins and exudates. Nevertheless, despite this variability propolis may have a general pharmacological value, and this review systematically compiles, for the first time, the existing preclinical and clinical evidence of propolis activities as an antiviral and immunomodulatory agent, focusing on the possible application in respiratory diseases. In vitro and in vivo assays have demonstrated propolis broad‐spectrum effects on viral infectivity and replication, as well as the modulatory actions on cytokine production and immune cell activation as part of both innate and adaptive immune responses. Clinical trials confirmed propolis undeniable potential as an effective therapeutic agent; however, the lack of rigorous randomized clinical trials in the context of respiratory diseases is tangible. Since propolis is available as a dietary supplement, possible use for the prevention of respiratory diseases and their deleterious inflammatory drawbacks on the respiratory tract in humans is considered and discussed. This review opens up new perspectives on the clinical investigation of neglected propolis biological properties which, now more than ever, are particularly relevant with respect to the recent outbreaks of pandemic respiratory infections.

31 October 2003 in Molecular Psychiatry
Verified
Journal Article
Open access
FFFabio Fumagalli
Fabio Fumagalli
GRG Racagni
G Racagni
ECElena Colombo
Elena Colombo
Marco Andrea RivaMarco Andrea Riva
Marco Andrea Riva
Molecular Psychiatry publishes work aimed at elucidating biological mechanisms underlying psychiatric disorders and their treatment

24 March 2017 in The World Journal of Biological Psychiatry
Verified
Journal Article
Closed access
ARAndrea Carlo Rossetti
Andrea Carlo Rossetti
MPMaria Serena Paladini
Maria Serena Paladini
GRGiorgio Racagni
Giorgio Racagni
Marco Andrea RivaMarco Andrea Riva
Marco Andrea Riva
ACAnnamaria Cattaneo
Annamaria Cattaneo
RMRaffaella Molteni
Raffaella Molteni
Objectives: Several studies reported that antidepressant drugs have immune-regulatory effects by acting on specific inflammatory mediators. However, considering the highly complex nature of the inflammatory response, we have adopted an unbiased genome-wide strategy to investigate the immune-regulatory activity of the antidepressant agomelatine in modulating the response to an acute inflammatory challenge. Methods: Microarray analysis was used to identify genes modulated in the ventral hippocampus of adult rats chronically treated with agomelatine (40 mg/kg, os) before being challenged with a single injection of lipopolysaccharide (LPS; 250 μg/kg, i.p.). Results: The administration of LPS induced the transcription of 284 genes mainly associated with pathways related to the immune/inflammatory system. Agomelatine modulated pathways not only connected to its antidepressant activity, but was also able to prevent the activation of genes induced by LPS. Further comparisons between gene lists of the diverse experimental groups led to the identification of a few transcripts modulated by LPS on which agomelatine has the larger effect of normalisation. Among them, we found the pro-inflammatory cytokine Il-1β and, interestingly, the metabotropic glutamatergic transporter Grm2. Conclusions: These results are useful to better characterise the association between depression and inflammation, revealing new potential targets for pharmacological intervention for depression associated to inflammation.

30 November 2020 in Future Neurology
Verified
Journal Article
Open access
CCChristoph Correll
Christoph Correll
KDKoen Demyttenaere
Koen Demyttenaere
AFAndrea Fagiolini
Andrea Fagiolini
GHGöran Hajak
Göran Hajak
Pallanti StefanoPallanti Stefano
Pallanti Stefano
SSSwaran Singh
Swaran Singh
In schizophrenia, dopaminergic hyperactivity in the mesolimbic regions, or possibly even selectively so in the dorsal striatum, seems to cause the emergence of psychotic symptoms, whereas dopaminer...

1 December 1992 in Pharmacological Research
Verified
Journal Article
Closed access
ARAnnalinda Rozza
Annalinda Rozza
GTGiulia La Torre
Giulia La Torre
CSCinzia Scavini
Cinzia Scavini
ELEnrica Lanza
Enrica Lanza
LFLuigia Favalli
Luigia Favalli
GRGiorgio Racagni
Giorgio Racagni

1 February 1998 in Human Psychopharmacology: Clinical and Experimental
Verified
Journal Article
Closed access
NBNicoletta Brunello
Nicoletta Brunello
GRGiorgio Racagni
Giorgio Racagni